Aurora Cannabis Inc. Share Price

Equities

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Toronto S.E. 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
9.19 CAD +0.33% Intraday chart for Aurora Cannabis Inc. +3.61% +41.38%

Financials

Sales 2024 * 272M 199M 15.93B Sales 2025 * 320M 234M 18.72B Capitalization 501M 366M 29.35B
Net income 2024 * -61M -44.59M -3.57B Net income 2025 * -7M -5.12M -410M EV / Sales 2024 * 1.84 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.57 x
P/E ratio 2024 *
-5.87 x
P/E ratio 2025 *
-56.6 x
Employees 1,130
Yield 2024 *
-
Yield 2025 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.33%
1 week+3.61%
Current month+54.97%
1 month+61.23%
3 months+71.78%
6 months+58.45%
Current year+41.38%
More quotes
1 week
8.46
Extreme 8.46
10.36
1 month
5.64
Extreme 5.64
11.97
Current year
3.84
Extreme 3.84
11.97
1 year
3.84
Extreme 3.84
15.50
3 years
3.84
Extreme 3.84
128.80
5 years
3.84
Extreme 3.84
1 514.41
10 years
3.84
Extreme 3.84
1 948.81
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 05/07/20
Director of Finance/CFO 52 02-20
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 67 24/07/18
Director/Board Member 60 19/05/16
Director/Board Member 52 09/08/15
More insiders
Date Price Change Volume
26/04/24 9.19 +0.33% 4,274,899
25/04/24 9.16 -6.44% 1,804,458
24/04/24 9.79 -2.97% 2,378,370
23/04/24 10.09 +17.87% 2,907,833
22/04/24 8.56 -3.49% 1,197,754

Delayed Quote Toronto S.E., April 26, 2024 at 09:00 pm

More quotes
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
9.19 CAD
Average target price
9.681 CAD
Spread / Average Target
+5.35%
Consensus